APO Research
Talk to an analyst

APO RESEARCH · REPORT

Large Volume Parenteral (LVP)

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

Selected research

Market Analysis & Forecast

Global Large Volume Parenteral (LVP) Market Analysis and Forecast 2026-2032

20 December 2025203 pages

Choose your research edition.

Industry ResearchLarge Volume Parenteral (LVP) Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Large Volume Parenteral (LVP) Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Large Volume Parenteral (LVP) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Large Volume Parenteral (LVP) Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Large Volume Parenteral (LVP) Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

The main Large Volume Parenteral (LVP) players include Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, etc. The top five Large Volume Parenteral (LVP) players account for approximately 66% of the total global market. Asia-Pacific is the largest consumer market for Large Volume Parenteral (LVP) accounting for about 47%, followed by Europe and North America. In terms of Type, Soft Bag LVP is the largest segment, with a share about 56%. And in terms of Application, the largest application is Therapeutic Infusion, followed by Basic Infusion.

This report presents an overview of global market for Large Volume Parenteral (LVP), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Large Volume Parenteral (LVP), also provides the sales of main regions and countries. Of the upcoming market potential for Large Volume Parenteral (LVP), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Large Volume Parenteral (LVP) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Large Volume Parenteral (LVP) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Large Volume Parenteral (LVP) sales, projected growth trends, production technology, application and end-user industry.

Large Volume Parenteral (LVP) Segment by Company

Baxter Healthcare

Kelun Pharma

B. Braun

Fresenius

Teva Pharmaceutical Industries

Pfizer (Hospira)

Ostuka Pharmaceutical

CR Double-Crane

Pisa

Huaren

Patheon

Beximco Pharma

Albert David

PSI Ltd

Ozon Pharmaceuticals

BAG Healthcare

BML Parenteral Drugs

Large Volume Parenteral (LVP) Segment by Type

Soft Bag LVP

Plastic Bottle LVP

Glass Bottle LVP

Large Volume Parenteral (LVP) Segment by Application

Basic Infusion

Therapeutic Infusion

Nutritious Infusion

Large Volume Parenteral (LVP) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Large Volume Parenteral (LVP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Large Volume Parenteral (LVP) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Large Volume Parenteral (LVP).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Large Volume Parenteral (LVP) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Large Volume Parenteral (LVP) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Large Volume Parenteral (LVP) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Large Volume Parenteral (LVP) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Soft Bag LVP Major Manufacturers Table 3. Plastic Bottle LVP Major Manufacturers Table 4. Glass Bottle LVP Major Manufacturers Table 5. Global Large Volume Parenteral (LVP) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Basic Infusion Major Manufacturers Table 7. Therapeutic Infusion Major Manufacturers Table 8. Nutritious Infusion Major Manufacturers Table 9. Large Volume Parenteral (LVP) Industry Trends Table 10. Large Volume Parenteral (LVP) Industry Drivers Table 11. Large Volume Parenteral (LVP) Industry Opportunities and Challenges Table 12. Large Volume Parenteral (LVP) Industry Restraints Table 13. Global Large Volume Parenteral (LVP) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Large Volume Parenteral (LVP) Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Large Volume Parenteral (LVP) Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2021-2026) Table 17. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2027-2032) Table 18. Global Large Volume Parenteral (LVP) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Units) Table 19. Global Large Volume Parenteral (LVP) Sales by Region (2021-2026) & (M Units) Table 20. Global Large Volume Parenteral (LVP) Sales by Region (2027-2032) & (M Units) Table 21. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2021-2026) Table 22. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2027-2032) Table 23. Global Large Volume Parenteral (LVP) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Large Volume Parenteral (LVP) Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Large Volume Parenteral (LVP) Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2021-2026) Table 27. Global Large Volume Parenteral (LVP) Sales Price (US$/K Units) of Manufacturers (2021-2026) Table 28. Global Large Volume Parenteral (LVP) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Large Volume Parenteral (LVP) Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Large Volume Parenteral (LVP) Manufacturers, Product Type & Application Table 31. Global Large Volume Parenteral (LVP) Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Large Volume Parenteral (LVP) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Large Volume Parenteral (LVP) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Large Volume Parenteral (LVP) Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Large Volume Parenteral (LVP) Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2021-2026) Table 38. Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2027-2032) Table 39. Global Large Volume Parenteral (LVP) Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 40. Global Large Volume Parenteral (LVP) Sales by Type (2021-2026) & (M Units) Table 41. Global Large Volume Parenteral (LVP) Sales by Type (2027-2032) & (M Units) Table 42. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2021-2026) Table 43. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2027-2032) Table 44. Global Large Volume Parenteral (LVP) Price by Type (2021-2026) & (US$/K Units) Table 45. Global Large Volume Parenteral (LVP) Price by Type (2027-2032) & (US$/K Units) Table 46. Global Large Volume Parenteral (LVP) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Large Volume Parenteral (LVP) Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Large Volume Parenteral (LVP) Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2021-2026) Table 50. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2027-2032) Table 51. Global Large Volume Parenteral (LVP) Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 52. Global Large Volume Parenteral (LVP) Sales by Application (2021-2026) & (M Units) Table 53. Global Large Volume Parenteral (LVP) Sales by Application (2027-2032) & (M Units) Table 54. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2021-2026) Table 55. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2027-2032) Table 56. Global Large Volume Parenteral (LVP) Price by Application (2021-2026) & (US$/K Units) Table 57. Global Large Volume Parenteral (LVP) Price by Application (2027-2032) & (US$/K Units) Table 58. Baxter Healthcare Company Information Table 59. Baxter Healthcare Business Overview Table 60. Baxter Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 61. Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio Table 62. Baxter Healthcare Recent Development Table 63. Kelun Pharma Company Information Table 64. Kelun Pharma Business Overview Table 65. Kelun Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 66. Kelun Pharma Large Volume Parenteral (LVP) Product Portfolio Table 67. Kelun Pharma Recent Development Table 68. B. Braun Company Information Table 69. B. Braun Business Overview Table 70. B. Braun Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 71. B. Braun Large Volume Parenteral (LVP) Product Portfolio Table 72. B. Braun Recent Development Table 73. Fresenius Company Information Table 74. Fresenius Business Overview Table 75. Fresenius Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 76. Fresenius Large Volume Parenteral (LVP) Product Portfolio Table 77. Fresenius Recent Development Table 78. Teva Pharmaceutical Industries Company Information Table 79. Teva Pharmaceutical Industries Business Overview Table 80. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 81. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Portfolio Table 82. Teva Pharmaceutical Industries Recent Development Table 83. Pfizer (Hospira) Company Information Table 84. Pfizer (Hospira) Business Overview Table 85. Pfizer (Hospira) Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 86. Pfizer (Hospira) Large Volume Parenteral (LVP) Product Portfolio Table 87. Pfizer (Hospira) Recent Development Table 88. Ostuka Pharmaceutical Company Information Table 89. Ostuka Pharmaceutical Business Overview Table 90. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 91. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio Table 92. Ostuka Pharmaceutical Recent Development Table 93. CR Double-Crane Company Information Table 94. CR Double-Crane Business Overview Table 95. CR Double-Crane Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 96. CR Double-Crane Large Volume Parenteral (LVP) Product Portfolio Table 97. CR Double-Crane Recent Development Table 98. Pisa Company Information Table 99. Pisa Business Overview Table 100. Pisa Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 101. Pisa Large Volume Parenteral (LVP) Product Portfolio Table 102. Pisa Recent Development Table 103. Huaren Company Information Table 104. Huaren Business Overview Table 105. Huaren Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 106. Huaren Large Volume Parenteral (LVP) Product Portfolio Table 107. Huaren Recent Development Table 108. Patheon Company Information Table 109. Patheon Business Overview Table 110. Patheon Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 111. Patheon Large Volume Parenteral (LVP) Product Portfolio Table 112. Patheon Recent Development Table 113. Beximco Pharma Company Information Table 114. Beximco Pharma Business Overview Table 115. Beximco Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 116. Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio Table 117. Beximco Pharma Recent Development Table 118. Albert David Company Information Table 119. Albert David Business Overview Table 120. Albert David Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 121. Albert David Large Volume Parenteral (LVP) Product Portfolio Table 122. Albert David Recent Development Table 123. PSI Ltd Company Information Table 124. PSI Ltd Business Overview Table 125. PSI Ltd Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 126. PSI Ltd Large Volume Parenteral (LVP) Product Portfolio Table 127. PSI Ltd Recent Development Table 128. Ozon Pharmaceuticals Company Information Table 129. Ozon Pharmaceuticals Business Overview Table 130. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 131. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio Table 132. Ozon Pharmaceuticals Recent Development Table 133. BAG Healthcare Company Information Table 134. BAG Healthcare Business Overview Table 135. BAG Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 136. BAG Healthcare Large Volume Parenteral (LVP) Product Portfolio Table 137. BAG Healthcare Recent Development Table 138. BML Parenteral Drugs Company Information Table 139. BML Parenteral Drugs Business Overview Table 140. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 141. BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio Table 142. BML Parenteral Drugs Recent Development Table 143. North America Large Volume Parenteral (LVP) Revenue by Type (2021-2026) & (US$ Million) Table 144. North America Large Volume Parenteral (LVP) Revenue by Type (2027-2032) & (US$ Million) Table 145. North America Large Volume Parenteral (LVP) Sales by Type (2021-2026) & (M Units) Table 146. North America Large Volume Parenteral (LVP) Sales by Type (2027-2032) & (M Units) Table 147. North America Large Volume Parenteral (LVP) Sales Price by Type (2021-2026) & (US$/K Units) Table 148. North America Large Volume Parenteral (LVP) Sales Price by Type (2027-2032) & (US$/K Units) Table 149. North America Large Volume Parenteral (LVP) Revenue by Application (2021-2026) & (US$ Million) Table 150. North America Large Volume Parenteral (LVP) Revenue by Application (2027-2032) & (US$ Million) Table 151. North America Large Volume Parenteral (LVP) Sales by Application (2021-2026) & (M Units) Table 152. North America Large Volume Parenteral (LVP) Sales by Application (2027-2032) & (M Units) Table 153. North America Large Volume Parenteral (LVP) Sales Price by Application (2021-2026) & (US$/K Units) Table 154. North America Large Volume Parenteral (LVP) Sales Price by Application (2027-2032) & (US$/K Units) Table 155. North America Large Volume Parenteral (LVP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. North America Large Volume Parenteral (LVP) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. North America Large Volume Parenteral (LVP) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. North America Large Volume Parenteral (LVP) Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 159. North America Large Volume Parenteral (LVP) Sales by Country (2021-2026) & (M Units) Table 160. North America Large Volume Parenteral (LVP) Sales by Country (2027-2032) & (M Units) Table 161. North America Large Volume Parenteral (LVP) Sales Price by Country (2021-2026) & (US$/K Units) Table 162. North America Large Volume Parenteral (LVP) Sales Price by Country (2027-2032) & (US$/K Units) Table 163. United States Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 164. Canada Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 165. Mexico Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 166. Europe Large Volume Parenteral (LVP) Revenue by Type (2021-2026) & (US$ Million) Table 167. Europe Large Volume Parenteral (LVP) Revenue by Type (2027-2032) & (US$ Million) Table 168. Europe Large Volume Parenteral (LVP) Sales by Type (2021-2026) & (M Units) Table 169. Europe Large Volume Parenteral (LVP) Sales by Type (2027-2032) & (M Units) Table 170. Europe Large Volume Parenteral (LVP) Sales Price by Type (2021-2026) & (US$/K Units) Table 171. Europe Large Volume Parenteral (LVP) Sales Price by Type (2027-2032) & (US$/K Units) Table 172. Europe Large Volume Parenteral (LVP) Revenue by Application (2021-2026) & (US$ Million) Table 173. Europe Large Volume Parenteral (LVP) Revenue by Application (2027-2032) & (US$ Million) Table 174. Europe Large Volume Parenteral (LVP) Sales by Application (2021-2026) & (M Units) Table 175. Europe Large Volume Parenteral (LVP) Sales by Application (2027-2032) & (M Units) Table 176. Europe Large Volume Parenteral (LVP) Sales Price by Application (2021-2026) & (US$/K Units) Table 177. Europe Large Volume Parenteral (LVP) Sales Price by Application (2027-2032) & (US$/K Units) Table 178. Europe Large Volume Parenteral (LVP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Europe Large Volume Parenteral (LVP) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Europe Large Volume Parenteral (LVP) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Europe Large Volume Parenteral (LVP) Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 182. Europe Large Volume Parenteral (LVP) Sales by Country (2021-2026) & (M Units) Table 183. Europe Large Volume Parenteral (LVP) Sales by Country (2027-2032) & (M Units) Table 184. Europe Large Volume Parenteral (LVP) Sales Price by Country (2021-2026) & (US$/K Units) Table 185. Europe Large Volume Parenteral (LVP) Sales Price by Country (2027-2032) & (US$/K Units) Table 186. Germany Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 187. France Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 188. U.K. Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 189. Italy Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 190. Russia Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 191. Spain Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 192. Netherlands Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 193. Switzerland Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 194. Sweden Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 195. Poland Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 196. China Large Volume Parenteral (LVP) Revenue by Type (2021-2026) & (US$ Million) Table 197. China Large Volume Parenteral (LVP) Revenue by Type (2027-2032) & (US$ Million) Table 198. China Large Volume Parenteral (LVP) Sales by Type (2021-2026) & (M Units) Table 199. China Large Volume Parenteral (LVP) Sales by Type (2027-2032) & (M Units) Table 200. China Large Volume Parenteral (LVP) Sales Price by Type (2021-2026) & (US$/K Units) Table 201. China Large Volume Parenteral (LVP) Sales Price by Type (2027-2032) & (US$/K Units) Table 202. China Large Volume Parenteral (LVP) Revenue by Application (2021-2026) & (US$ Million) Table 203. China Large Volume Parenteral (LVP) Revenue by Application (2027-2032) & (US$ Million) Table 204. China Large Volume Parenteral (LVP) Sales by Application (2021-2026) & (M Units) Table 205. China Large Volume Parenteral (LVP) Sales by Application (2027-2032) & (M Units) Table 206. China Large Volume Parenteral (LVP) Sales Price by Application (2021-2026) & (US$/K Units) Table 207. China Large Volume Parenteral (LVP) Sales Price by Application (2027-2032) & (US$/K Units) Table 208. Asia Large Volume Parenteral (LVP) Revenue by Type (2021-2026) & (US$ Million) Table 209. Asia Large Volume Parenteral (LVP) Revenue by Type (2027-2032) & (US$ Million) Table 210. Asia Large Volume Parenteral (LVP) Sales by Type (2021-2026) & (M Units) Table 211. Asia Large Volume Parenteral (LVP) Sales by Type (2027-2032) & (M Units) Table 212. Asia Large Volume Parenteral (LVP) Sales Price by Type (2021-2026) & (US$/K Units) Table 213. Asia Large Volume Parenteral (LVP) Sales Price by Type (2027-2032) & (US$/K Units) Table 214. Asia Large Volume Parenteral (LVP) Revenue by Application (2021-2026) & (US$ Million) Table 215. Asia Large Volume Parenteral (LVP) Revenue by Application (2027-2032) & (US$ Million) Table 216. Asia Large Volume Parenteral (LVP) Sales by Application (2021-2026) & (M Units) Table 217. Asia Large Volume Parenteral (LVP) Sales by Application (2027-2032) & (M Units) Table 218. Asia Large Volume Parenteral (LVP) Sales Price by Application (2021-2026) & (US$/K Units) Table 219. Asia Large Volume Parenteral (LVP) Sales Price by Application (2027-2032) & (US$/K Units) Table 220. Asia Large Volume Parenteral (LVP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. Asia Large Volume Parenteral (LVP) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. Asia Large Volume Parenteral (LVP) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. Asia Large Volume Parenteral (LVP) Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 224. Asia Large Volume Parenteral (LVP) Sales by Country (2021-2026) & (M Units) Table 225. Asia Large Volume Parenteral (LVP) Sales by Country (2027-2032) & (M Units) Table 226. Asia Large Volume Parenteral (LVP) Sales Price by Country (2021-2026) & (US$/K Units) Table 227. Asia Large Volume Parenteral (LVP) Sales Price by Country (2027-2032) & (US$/K Units) Table 228. Japan Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 229. South Korea Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 230. India Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 231. Australia Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 232. Taiwan Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 233. Southeast Asia Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 234. SAMEA Large Volume Parenteral (LVP) Revenue by Type (2021-2026) & (US$ Million) Table 235. SAMEA Large Volume Parenteral (LVP) Revenue by Type (2027-2032) & (US$ Million) Table 236. SAMEA Large Volume Parenteral (LVP) Sales by Type (2021-2026) & (M Units) Table 237. SAMEA Large Volume Parenteral (LVP) Sales by Type (2027-2032) & (M Units) Table 238. SAMEA Large Volume Parenteral (LVP) Sales Price by Type (2021-2026) & (US$/K Units) Table 239. SAMEA Large Volume Parenteral (LVP) Sales Price by Type (2027-2032) & (US$/K Units) Table 240. SAMEA Large Volume Parenteral (LVP) Revenue by Application (2021-2026) & (US$ Million) Table 241. SAMEA Large Volume Parenteral (LVP) Revenue by Application (2027-2032) & (US$ Million) Table 242. SAMEA Large Volume Parenteral (LVP) Sales by Application (2021-2026) & (M Units) Table 243. SAMEA Large Volume Parenteral (LVP) Sales by Application (2027-2032) & (M Units) Table 244. SAMEA Large Volume Parenteral (LVP) Sales Price by Application (2021-2026) & (US$/K Units) Table 245. SAMEA Large Volume Parenteral (LVP) Sales Price by Application (2027-2032) & (US$/K Units) Table 246. SAMEA Large Volume Parenteral (LVP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 247. SAMEA Large Volume Parenteral (LVP) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 248. SAMEA Large Volume Parenteral (LVP) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 249. SAMEA Large Volume Parenteral (LVP) Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 250. SAMEA Large Volume Parenteral (LVP) Sales by Country (2021-2026) & (M Units) Table 251. SAMEA Large Volume Parenteral (LVP) Sales by Country (2027-2032) & (M Units) Table 252. SAMEA Large Volume Parenteral (LVP) Sales Price by Country (2021-2026) & (US$/K Units) Table 253. SAMEA Large Volume Parenteral (LVP) Sales Price by Country (2027-2032) & (US$/K Units) Table 254. Brazil Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 255. Argentina Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 256. Chile Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 257. Colombia Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 258. Peru Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 259. Saudi Arabia Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 260. Israel Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 261. UAE Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 262. Turkey Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 263. Iran Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 264. Egypt Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Table 265. Key Raw Materials Table 266. Raw Materials Key Suppliers Table 267. Large Volume Parenteral (LVP) Distributors List Table 268. Large Volume Parenteral (LVP) Customers List Table 269. Research Programs/Design for This Report Table 270. Authors List of This Report Table 271. Secondary Sources Table 272. Primary Sources List of Figures Figure 1. Large Volume Parenteral (LVP) Image Figure 2. Global Large Volume Parenteral (LVP) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Large Volume Parenteral (LVP) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Soft Bag LVP Image Figure 5. Plastic Bottle LVP Image Figure 6. Glass Bottle LVP Image Figure 7. Global Large Volume Parenteral (LVP) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Large Volume Parenteral (LVP) Market Size Share 2021 VS 2025 VS 2032 Figure 9. Basic Infusion Image Figure 10. Therapeutic Infusion Image Figure 11. Nutritious Infusion Image Figure 12. Global Large Volume Parenteral (LVP) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Large Volume Parenteral (LVP) Revenue (2021-2032) & (US$ Million) Figure 14. Global Large Volume Parenteral (LVP) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Large Volume Parenteral (LVP) Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2021-2032) Figure 17. Global Large Volume Parenteral (LVP) Sales (2021-2032) & (M Units) Figure 18. Global Large Volume Parenteral (LVP) Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 19. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Large Volume Parenteral (LVP) Sales YoY (2021-2032) & (M Units) Figure 21. Europe Large Volume Parenteral (LVP) Sales YoY (2021-2032) & (M Units) Figure 22. China Large Volume Parenteral (LVP) Sales YoY (2021-2032) & (M Units) Figure 23. Asia (Excluding China) Large Volume Parenteral (LVP) Sales YoY (2021-2032) & (M Units) Figure 24. South America, Middle East and Africa Large Volume Parenteral (LVP) Sales YoY (2021-2032) & (M Units) Figure 25. Global Large Volume Parenteral (LVP) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Large Volume Parenteral (LVP) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Large Volume Parenteral (LVP) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Large Volume Parenteral (LVP) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2021-2032) Figure 31. Global Large Volume Parenteral (LVP) Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 32. Global Large Volume Parenteral (LVP) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2021-2032) Figure 34. Global Large Volume Parenteral (LVP) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Large Volume Parenteral (LVP) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2021-2032) Figure 37. Global Large Volume Parenteral (LVP) Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 38. Global Large Volume Parenteral (LVP) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2021-2032) Figure 40. North America Large Volume Parenteral (LVP) Revenue Share by Type (2021-2032) Figure 41. North America Large Volume Parenteral (LVP) Sales Share by Type (2021-2032) Figure 42. North America Large Volume Parenteral (LVP) Revenue Share by Application (2021-2032) Figure 43. North America Large Volume Parenteral (LVP) Sales Share by Application (2021-2032) Figure 44. North America Large Volume Parenteral (LVP) Revenue Share by Country (2021-2032) Figure 45. North America Large Volume Parenteral (LVP) Sales Share by Country (2021-2032) Figure 46. Europe Large Volume Parenteral (LVP) Revenue Share by Type (2021-2032) Figure 47. Europe Large Volume Parenteral (LVP) Sales Share by Type (2021-2032) Figure 48. Europe Large Volume Parenteral (LVP) Revenue Share by Application (2021-2032) Figure 49. Europe Large Volume Parenteral (LVP) Sales Share by Application (2021-2032) Figure 50. Europe Large Volume Parenteral (LVP) Revenue Share by Country (2021-2032) Figure 51. Europe Large Volume Parenteral (LVP) Sales Share by Country (2021-2032) Figure 52. China Large Volume Parenteral (LVP) Revenue Share by Type (2021-2032) Figure 53. China Large Volume Parenteral (LVP) Sales Share by Type (2021-2032) Figure 54. China Large Volume Parenteral (LVP) Revenue Share by Application (2021-2032) Figure 55. China Large Volume Parenteral (LVP) Sales Share by Application (2021-2032) Figure 56. Asia Large Volume Parenteral (LVP) Revenue Share by Type (2021-2032) Figure 57. Asia Large Volume Parenteral (LVP) Sales Share by Type (2021-2032) Figure 58. Asia Large Volume Parenteral (LVP) Revenue Share by Application (2021-2032) Figure 59. Asia Large Volume Parenteral (LVP) Sales Share by Application (2021-2032) Figure 60. Asia Large Volume Parenteral (LVP) Revenue Share by Country (2021-2032) Figure 61. Asia Large Volume Parenteral (LVP) Sales Share by Country (2021-2032) Figure 62. SAMEA Large Volume Parenteral (LVP) Revenue Share by Type (2021-2032) Figure 63. SAMEA Large Volume Parenteral (LVP) Sales Share by Type (2021-2032) Figure 64. SAMEA Large Volume Parenteral (LVP) Revenue Share by Application (2021-2032) Figure 65. SAMEA Large Volume Parenteral (LVP) Sales Share by Application (2021-2032) Figure 66. SAMEA Large Volume Parenteral (LVP) Revenue Share by Country (2021-2032) Figure 67. SAMEA Large Volume Parenteral (LVP) Sales Share by Country (2021-2032) Figure 68. Large Volume Parenteral (LVP) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Large Volume Parenteral (LVP) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Soft Bag LVP
  • Plastic Bottle LVP
  • Glass Bottle LVP
Applications
  • Basic Infusion
  • Therapeutic Infusion
  • Nutritious Infusion
Companies covered
  • Baxter Healthcare
  • Kelun Pharma
  • B. Braun
  • Fresenius
  • Teva Pharmaceutical Industries
  • Pfizer (Hospira)
  • Ostuka Pharmaceutical
  • CR Double-Crane
  • Pisa
  • Huaren
  • Patheon
  • Beximco Pharma
  • Albert David
  • PSI Ltd
  • Ozon Pharmaceuticals
  • BAG Healthcare
  • BML Parenteral Drugs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Large Volume Parenteral (LVP) Market by Type
  3. 1.2.1 Global Large Volume Parenteral (LVP) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Soft Bag LVP
  5. 1.2.3 Plastic Bottle LVP
  6. 1.2.4 Glass Bottle LVP
  7. 1.3 Large Volume Parenteral (LVP) Market by Application
  8. 1.3.1 Global Large Volume Parenteral (LVP) Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Basic Infusion
  10. 1.3.3 Therapeutic Infusion
  11. 1.3.4 Nutritious Infusion
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Large Volume Parenteral (LVP) Market Dynamics
  1. 2.1 Large Volume Parenteral (LVP) Industry Trends
  2. 2.2 Large Volume Parenteral (LVP) Industry Drivers
  3. 2.3 Large Volume Parenteral (LVP) Industry Opportunities and Challenges
  4. 2.4 Large Volume Parenteral (LVP) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Large Volume Parenteral (LVP) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Large Volume Parenteral (LVP) Revenue by Region
  3. 3.2.1 Global Large Volume Parenteral (LVP) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Large Volume Parenteral (LVP) Revenue by Region (2021-2026)
  5. 3.2.3 Global Large Volume Parenteral (LVP) Revenue by Region (2027-2032)
  6. 3.2.4 Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Large Volume Parenteral (LVP) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Large Volume Parenteral (LVP) Sales by Region
  9. 3.4.1 Global Large Volume Parenteral (LVP) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Large Volume Parenteral (LVP) Sales by Region (2021-2026)
  11. 3.4.3 Global Large Volume Parenteral (LVP) Sales by Region (2027-2032)
  12. 3.4.4 Global Large Volume Parenteral (LVP) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Large Volume Parenteral (LVP) Revenue by Manufacturers
  2. 4.1.1 Global Large Volume Parenteral (LVP) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Large Volume Parenteral (LVP) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Large Volume Parenteral (LVP) Sales by Manufacturers
  6. 4.2.1 Global Large Volume Parenteral (LVP) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Large Volume Parenteral (LVP) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Large Volume Parenteral (LVP) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Large Volume Parenteral (LVP) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Large Volume Parenteral (LVP) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Large Volume Parenteral (LVP) Manufacturers, Product Type & Application
  13. 4.7 Global Large Volume Parenteral (LVP) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Large Volume Parenteral (LVP) Market CR5 and HHI
  16. 4.8.2 2025 Large Volume Parenteral (LVP) Tier 1, Tier 2, and Tier 3
5 Large Volume Parenteral (LVP) Market by Type
  1. 5.1 Global Large Volume Parenteral (LVP) Revenue by Type
  2. 5.1.1 Global Large Volume Parenteral (LVP) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Large Volume Parenteral (LVP) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Large Volume Parenteral (LVP) Sales by Type
  6. 5.2.1 Global Large Volume Parenteral (LVP) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Large Volume Parenteral (LVP) Sales by Type (2021-2032) & (M Units)
  8. 5.2.3 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Large Volume Parenteral (LVP) Price by Type
6 Large Volume Parenteral (LVP) Market by Application
  1. 6.1 Global Large Volume Parenteral (LVP) Revenue by Application
  2. 6.1.1 Global Large Volume Parenteral (LVP) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Large Volume Parenteral (LVP) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Large Volume Parenteral (LVP) Sales by Application
  6. 6.2.1 Global Large Volume Parenteral (LVP) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Large Volume Parenteral (LVP) Sales by Application (2021-2032) & (M Units)
  8. 6.2.3 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Large Volume Parenteral (LVP) Price by Application
7 Company Profiles
  1. 7.1 Baxter Healthcare
  2. 7.1.1 Baxter Healthcare Company Information
  3. 7.1.2 Baxter Healthcare Business Overview
  4. 7.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio
  6. 7.1.5 Baxter Healthcare Recent Developments
  7. 7.2 Kelun Pharma
  8. 7.2.1 Kelun Pharma Company Information
  9. 7.2.2 Kelun Pharma Business Overview
  10. 7.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Kelun Pharma Large Volume Parenteral (LVP) Product Portfolio
  12. 7.2.5 Kelun Pharma Recent Developments
  13. 7.3 B. Braun
  14. 7.3.1 B. Braun Company Information
  15. 7.3.2 B. Braun Business Overview
  16. 7.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 B. Braun Large Volume Parenteral (LVP) Product Portfolio
  18. 7.3.5 B. Braun Recent Developments
  19. 7.4 Fresenius
  20. 7.4.1 Fresenius Company Information
  21. 7.4.2 Fresenius Business Overview
  22. 7.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Fresenius Large Volume Parenteral (LVP) Product Portfolio
  24. 7.4.5 Fresenius Recent Developments
  25. 7.5 Teva Pharmaceutical Industries
  26. 7.5.1 Teva Pharmaceutical Industries Company Information
  27. 7.5.2 Teva Pharmaceutical Industries Business Overview
  28. 7.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Portfolio
  30. 7.5.5 Teva Pharmaceutical Industries Recent Developments
  31. 7.6 Pfizer (Hospira)
  32. 7.6.1 Pfizer (Hospira) Company Information
  33. 7.6.2 Pfizer (Hospira) Business Overview
  34. 7.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Product Portfolio
  36. 7.6.5 Pfizer (Hospira) Recent Developments
  37. 7.7 Ostuka Pharmaceutical
  38. 7.7.1 Ostuka Pharmaceutical Company Information
  39. 7.7.2 Ostuka Pharmaceutical Business Overview
  40. 7.7.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
  42. 7.7.5 Ostuka Pharmaceutical Recent Developments
  43. 7.8 CR Double-Crane
  44. 7.8.1 CR Double-Crane Company Information
  45. 7.8.2 CR Double-Crane Business Overview
  46. 7.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 CR Double-Crane Large Volume Parenteral (LVP) Product Portfolio
  48. 7.8.5 CR Double-Crane Recent Developments
  49. 7.9 Pisa
  50. 7.9.1 Pisa Company Information
  51. 7.9.2 Pisa Business Overview
  52. 7.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Pisa Large Volume Parenteral (LVP) Product Portfolio
  54. 7.9.5 Pisa Recent Developments
  55. 7.10 Huaren
  56. 7.10.1 Huaren Company Information
  57. 7.10.2 Huaren Business Overview
  58. 7.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Huaren Large Volume Parenteral (LVP) Product Portfolio
  60. 7.10.5 Huaren Recent Developments
  61. 7.11 Patheon
  62. 7.11.1 Patheon Company Information
  63. 7.11.2 Patheon Business Overview
  64. 7.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Patheon Large Volume Parenteral (LVP) Product Portfolio
  66. 7.11.5 Patheon Recent Developments
  67. 7.12 Beximco Pharma
  68. 7.12.1 Beximco Pharma Company Information
  69. 7.12.2 Beximco Pharma Business Overview
  70. 7.12.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio
  72. 7.12.5 Beximco Pharma Recent Developments
  73. 7.13 Albert David
  74. 7.13.1 Albert David Company Information
  75. 7.13.2 Albert David Business Overview
  76. 7.13.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Albert David Large Volume Parenteral (LVP) Product Portfolio
  78. 7.13.5 Albert David Recent Developments
  79. 7.14 PSI Ltd
  80. 7.14.1 PSI Ltd Company Information
  81. 7.14.2 PSI Ltd Business Overview
  82. 7.14.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 PSI Ltd Large Volume Parenteral (LVP) Product Portfolio
  84. 7.14.5 PSI Ltd Recent Developments
  85. 7.15 Ozon Pharmaceuticals
  86. 7.15.1 Ozon Pharmaceuticals Company Information
  87. 7.15.2 Ozon Pharmaceuticals Business Overview
  88. 7.15.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio
  90. 7.15.5 Ozon Pharmaceuticals Recent Developments
  91. 7.16 BAG Healthcare
  92. 7.16.1 BAG Healthcare Company Information
  93. 7.16.2 BAG Healthcare Business Overview
  94. 7.16.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 BAG Healthcare Large Volume Parenteral (LVP) Product Portfolio
  96. 7.16.5 BAG Healthcare Recent Developments
  97. 7.17 BML Parenteral Drugs
  98. 7.17.1 BML Parenteral Drugs Company Information
  99. 7.17.2 BML Parenteral Drugs Business Overview
  100. 7.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio
  102. 7.17.5 BML Parenteral Drugs Recent Developments
8 North America
  1. 8.1 North America Large Volume Parenteral (LVP) Market Size by Type
  2. 8.1.1 North America Large Volume Parenteral (LVP) Revenue by Type (2021-2032)
  3. 8.1.2 North America Large Volume Parenteral (LVP) Sales by Type (2021-2032)
  4. 8.1.3 North America Large Volume Parenteral (LVP) Price by Type (2021-2032)
  5. 8.2 North America Large Volume Parenteral (LVP) Market Size by Application
  6. 8.2.1 North America Large Volume Parenteral (LVP) Revenue by Application (2021-2032)
  7. 8.2.2 North America Large Volume Parenteral (LVP) Sales by Application (2021-2032)
  8. 8.2.3 North America Large Volume Parenteral (LVP) Price by Application (2021-2032)
  9. 8.3 North America Large Volume Parenteral (LVP) Market Size by Country
  10. 8.3.1 North America Large Volume Parenteral (LVP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Large Volume Parenteral (LVP) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Large Volume Parenteral (LVP) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Large Volume Parenteral (LVP) Market Size by Type
  2. 9.1.1 Europe Large Volume Parenteral (LVP) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Large Volume Parenteral (LVP) Sales by Type (2021-2032)
  4. 9.1.3 Europe Large Volume Parenteral (LVP) Price by Type (2021-2032)
  5. 9.2 Europe Large Volume Parenteral (LVP) Market Size by Application
  6. 9.2.1 Europe Large Volume Parenteral (LVP) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Large Volume Parenteral (LVP) Sales by Application (2021-2032)
  8. 9.2.3 Europe Large Volume Parenteral (LVP) Price by Application (2021-2032)
  9. 9.3 Europe Large Volume Parenteral (LVP) Market Size by Country
  10. 9.3.1 Europe Large Volume Parenteral (LVP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Large Volume Parenteral (LVP) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Large Volume Parenteral (LVP) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Large Volume Parenteral (LVP) Market Size by Type
  2. 10.1.1 China Large Volume Parenteral (LVP) Revenue by Type (2021-2032)
  3. 10.1.2 China Large Volume Parenteral (LVP) Sales by Type (2021-2032)
  4. 10.1.3 China Large Volume Parenteral (LVP) Price by Type (2021-2032)
  5. 10.2 China Large Volume Parenteral (LVP) Market Size by Application
  6. 10.2.1 China Large Volume Parenteral (LVP) Revenue by Application (2021-2032)
  7. 10.2.2 China Large Volume Parenteral (LVP) Sales by Application (2021-2032)
  8. 10.2.3 China Large Volume Parenteral (LVP) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Large Volume Parenteral (LVP) Market Size by Type
  2. 11.1.1 Asia Large Volume Parenteral (LVP) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Large Volume Parenteral (LVP) Sales by Type (2021-2032)
  4. 11.1.3 Asia Large Volume Parenteral (LVP) Price by Type (2021-2032)
  5. 11.2 Asia Large Volume Parenteral (LVP) Market Size by Application
  6. 11.2.1 Asia Large Volume Parenteral (LVP) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Large Volume Parenteral (LVP) Sales by Application (2021-2032)
  8. 11.2.3 Asia Large Volume Parenteral (LVP) Price by Application (2021-2032)
  9. 11.3 Asia Large Volume Parenteral (LVP) Market Size by Country
  10. 11.3.1 Asia Large Volume Parenteral (LVP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Large Volume Parenteral (LVP) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Large Volume Parenteral (LVP) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Large Volume Parenteral (LVP) Market Size by Type
  2. 12.1.1 SAMEA Large Volume Parenteral (LVP) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Large Volume Parenteral (LVP) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Large Volume Parenteral (LVP) Price by Type (2021-2032)
  5. 12.2 SAMEA Large Volume Parenteral (LVP) Market Size by Application
  6. 12.2.1 SAMEA Large Volume Parenteral (LVP) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Large Volume Parenteral (LVP) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Large Volume Parenteral (LVP) Price by Application (2021-2032)
  9. 12.3 SAMEA Large Volume Parenteral (LVP) Market Size by Country
  10. 12.3.1 SAMEA Large Volume Parenteral (LVP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Large Volume Parenteral (LVP) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Large Volume Parenteral (LVP) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Large Volume Parenteral (LVP) Value Chain Analysis
  2. 13.1.1 Large Volume Parenteral (LVP) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Large Volume Parenteral (LVP) Production Mode & Process
  6. 13.2 Large Volume Parenteral (LVP) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Large Volume Parenteral (LVP) Distributors
  9. 13.2.3 Large Volume Parenteral (LVP) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst